A transcriptomic atlas of chronic lung allograft dysfunction
European Respiratory Journal · 2026-10 · 68 (4) · 2502380
DOI: 10.1183/13993003.02380-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 02.07.2026. Verfasst von Hanne Beeckmans und 38 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KULeuven, Leuven, Belgium hanne.beeckmans@hotmail.com. Hauptthemen laut MEDLINE: Lung Transplantation, Bronchiolitis Obliterans Syndrome, Transcriptome, Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Background
Chronic lung allograft dysfunction (CLAD) is the leading cause of late mortality after lung transplantation. Bronchiolitis obliterans syndrome (BOS) and restrictive allograft syndrome (RAS) are the main underlying clinical entities. Their molecular and cellular signatures are unclear and, therefore, we aimed to identify molecular programmes associated with morphological disease severity in CLAD.
Methods
We performed high-resolution imaging-based gene expression profiling of 128 lung samples from explanted CLAD and donor lungs, using weighted gene co-expression network analysis, cellular and pathway enrichment, and hub gene identification. Findings were validated across four datasets, including a murine transplant model, human BOS lungs, transbronchial biopsies, and bronchoalveolar lavage fluid of lung transplant recipients.
Results
Unsupervised clustering revealed two transcriptomic CLAD endotypes aligning with mild-fibrotic (BOS, mild RAS) and advanced-fibrotic disease (moderate/severe RAS). Samples from the same patient often diverged molecularly, underscoring intrapatient heterogeneity and limitations of current phenotypical classification. Five molecular programmes emerged: 1) epithelial stress and innate immunity in early-fibrotic CLAD; 2) progressive adaptive immunity and cytotoxicity in advanced CLAD; 3) transient extracellular matrix remodelling; 4) progressive endothelial loss/dysfunction; and 5) progressive loss of homeostasis, wherein multiple potential druggable targets were detected. Finally, we identified a 26 CLAD-hub-gene panel, which showed robust diagnostic performance to discriminate CLAD.
Conclusion
CLAD is a spatially heterogeneous, yet molecularly continuous disease process, wherein BOS and RAS represent variable stages of a shared immunopathological continuum. Our findings support the development of lung-specific molecular classifiers to guide diagnostics and reveal novel targets for personalised therapies in transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KULeuven, Leuven, Belgium hanne.beeckmans@hotmail.com.
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), KULeuven, Leuven, Belgium.
- Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
- Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
- Chest Department, Hôpital Universitaire de Bruxelles Erasme, Université Libre de Bruxelles, Brussels, Belgium.
- Department of Imaging and Pathology, Translational Cell and Tissue Research, KULeuven, Leuven, Belgium.
ORCID-Profile: Hanne Beeckmans, Pieterjan Kerckhof, Vincent Geudens, Cedric Vanluyten, Marta Zapata-Ortega, Lynn Willems, Anke Van Herck, Astrid Vermaut, Gitte Aerts, Charlotte Hooft, Xin Jin, Jan Van Slambrouck, Andrea Zajacova, Martina Mercurio, Emanuela Cortesi, Yousry Mohamady, Birger Tielemans, Christiane Knoop, Wim Janssens, Ghislaine Gayan-Ramirez, Wim A Wuyts, Laurent Godinas, Saskia Bos, Els Wauters, Lieven J Dupont, Dirk Van Raemdonck, Birgit Weynand, Berta Saez-Gimenez, Herbert B Schiller, Jonas C Schupp, Nikolaus Kneidinger, Laurens J De Sadeleer, Farida Ahangari, John E McDonough, Laurens J Ceulemans, Ali Ö Yildirim, Naftali Kaminski, Bart M Vanaudenaerde, Robin Vos
Förderung
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Beeckmans, H., Kerckhof, P., Geudens, V., Vanluyten, C., Zapata-Ortega, M., Willems, L., Van Herck, A., Vermaut, A., Aerts, G., Hooft, C., Jin, X., Van Slambrouck, J., Zajacova, A., Mercurio, M., Cortesi, E., Mohamady, Y., Tielemans, B., Knoop, C., Janssens, W., …, & Vos, R. (2026). A transcriptomic atlas of chronic lung allograft dysfunction. European Respiratory Journal, 68(4), 2502380. https://doi.org/10.1183/13993003.02380-2025
Vancouver
Beeckmans H, Kerckhof P, Geudens V, Vanluyten C, Zapata-Ortega M, Willems L, et al. A transcriptomic atlas of chronic lung allograft dysfunction. European Respiratory Journal. 2026;68(4):2502380. doi:10.1183/13993003.02380-2025
BibTeX
@article{Beeckmans2026,
author = {Beeckmans, Hanne and Kerckhof, Pieterjan and Geudens, Vincent and Vanluyten, Cedric and Zapata-Ortega, Marta and Willems, Lynn and Van Herck, Anke and Vermaut, Astrid and Aerts, Gitte and Hooft, Charlotte and Jin, Xin and Van Slambrouck, Jan and Zajacova, Andrea and Mercurio, Martina and Cortesi, Emanuela and Mohamady, Yousry and Tielemans, Birger and Knoop, Christiane and Janssens, Wim and Gayan-Ramirez, Ghislaine and Wuyts, Wim A and Godinas, Laurent and Bos, Saskia and Wauters, Els and Dupont, Lieven J and Van Raemdonck, Dirk and Weynand, Birgit and Saez-Gimenez, Berta and Schiller, Herbert B and Schupp, Jonas C and Kneidinger, Nikolaus and De Sadeleer, Laurens J and Ahangari, Farida and McDonough, John E and Ceulemans, Laurens J and Yildirim, Ali Ö and Kaminski, Naftali and Vanaudenaerde, Bart M and Vos, Robin},
title = {A transcriptomic atlas of chronic lung allograft dysfunction},
journal = {European Respiratory Journal},
year = {2026},
volume = {68},
number = {4},
pages = {2502380},
doi = {10.1183/13993003.02380-2025}
}
EUVIMED